| Literature DB >> 33585509 |
Marion Cremoni1,2, Caroline Ruetsch3, Kévin Zorzi2,4, Céline Fernandez2,4, Sonia Boyer-Suavet2,4, Sylvia Benzaken3, Elisa Demonchy5, Jean Dellamonica2,6, Carole Ichai7, Vincent Esnault1,2,4, Vesna Brglez2,4, Barbara Seitz-Polski1,2,3,4.
Abstract
Frontline health care workers (HCWs) have been particularly exposed to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) since the start of the pandemic but the clinical features and immune responses of those infected with SARS-CoV-2 have not been well described. In a prospective single center cohort study, we enrolled 196 frontline HCWs exposed to the SARS-Cov-2 and 60 patients with moderate and severe forms of the coronavirus disease 2019 (COVID-19). Serological tests and cytokines assay were performed to analyze SARS-CoV-2-specific humoral and cellular immunity. Of the 196 HCWs tested, 15% had specific antibodies against SARS-CoV-2 and 45% of seropositive HCWs were strictly asymptomatic. However, in comparison to moderate and severe forms, HCWs with mild or asymptomatic forms of COVID-19 showed lower specific IgA and IgG peaks, consistent with their mild symptoms, and a robust immune cellular response, illustrated by a high production of type I and II interferons. Further studies are needed to evaluate whether this interferon functional immune assay, routinely applicable, can be useful in predicting the risk of severe forms of COVID-19.Entities:
Keywords: COVID-19; SARS-CoV-2; blood immune biomarkers; cellular response; health care workers; humoral response
Year: 2021 PMID: 33585509 PMCID: PMC7873459 DOI: 10.3389/fmed.2020.608804
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X